Malignant hepatic tumors

Safety of high-dose percutaneous ethanol ablation therapy

Richard D. Redvanly, Judith L. Chezmar, Robert M. Strauss, John R. Galloway, Thomas D Boyer, Michael E. Bernardino

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

The authors retrospectively analyzed clinical records to determine the safety and complication rate of percutaneous ethanol ablation therapy with more than 10 mL of ethanol administered per session for treatment of malignant hepatic tumors. Ten patients underwent a total of 35 sessions with 10 mL or more of ethanol, and four underwent 18 sessions with 10 mL or less. No serious complications occurred with any dose. Pain and fever were the most common complications at all doses, and the higher frequency of these at larger ethanol volumes may be related to the greater degree of tumor necrosis induced by the larger volume.

Original languageEnglish (US)
Pages (from-to)283-285
Number of pages3
JournalRadiology
Volume188
Issue number1
StatePublished - Jul 1993
Externally publishedYes

Fingerprint

Ethanol
Safety
Liver
Neoplasms
Therapeutics
Fever
Necrosis
Pain

Keywords

  • Alcohol, 761.1269
  • Liver neoplasms, therapy, 761.1269, 761.323
  • Liver, interventional procedures, 761.1269

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Redvanly, R. D., Chezmar, J. L., Strauss, R. M., Galloway, J. R., Boyer, T. D., & Bernardino, M. E. (1993). Malignant hepatic tumors: Safety of high-dose percutaneous ethanol ablation therapy. Radiology, 188(1), 283-285.

Malignant hepatic tumors : Safety of high-dose percutaneous ethanol ablation therapy. / Redvanly, Richard D.; Chezmar, Judith L.; Strauss, Robert M.; Galloway, John R.; Boyer, Thomas D; Bernardino, Michael E.

In: Radiology, Vol. 188, No. 1, 07.1993, p. 283-285.

Research output: Contribution to journalArticle

Redvanly, RD, Chezmar, JL, Strauss, RM, Galloway, JR, Boyer, TD & Bernardino, ME 1993, 'Malignant hepatic tumors: Safety of high-dose percutaneous ethanol ablation therapy', Radiology, vol. 188, no. 1, pp. 283-285.
Redvanly RD, Chezmar JL, Strauss RM, Galloway JR, Boyer TD, Bernardino ME. Malignant hepatic tumors: Safety of high-dose percutaneous ethanol ablation therapy. Radiology. 1993 Jul;188(1):283-285.
Redvanly, Richard D. ; Chezmar, Judith L. ; Strauss, Robert M. ; Galloway, John R. ; Boyer, Thomas D ; Bernardino, Michael E. / Malignant hepatic tumors : Safety of high-dose percutaneous ethanol ablation therapy. In: Radiology. 1993 ; Vol. 188, No. 1. pp. 283-285.
@article{f239aa8cde4c44d4be3a8efe0af780ee,
title = "Malignant hepatic tumors: Safety of high-dose percutaneous ethanol ablation therapy",
abstract = "The authors retrospectively analyzed clinical records to determine the safety and complication rate of percutaneous ethanol ablation therapy with more than 10 mL of ethanol administered per session for treatment of malignant hepatic tumors. Ten patients underwent a total of 35 sessions with 10 mL or more of ethanol, and four underwent 18 sessions with 10 mL or less. No serious complications occurred with any dose. Pain and fever were the most common complications at all doses, and the higher frequency of these at larger ethanol volumes may be related to the greater degree of tumor necrosis induced by the larger volume.",
keywords = "Alcohol, 761.1269, Liver neoplasms, therapy, 761.1269, 761.323, Liver, interventional procedures, 761.1269",
author = "Redvanly, {Richard D.} and Chezmar, {Judith L.} and Strauss, {Robert M.} and Galloway, {John R.} and Boyer, {Thomas D} and Bernardino, {Michael E.}",
year = "1993",
month = "7",
language = "English (US)",
volume = "188",
pages = "283--285",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - Malignant hepatic tumors

T2 - Safety of high-dose percutaneous ethanol ablation therapy

AU - Redvanly, Richard D.

AU - Chezmar, Judith L.

AU - Strauss, Robert M.

AU - Galloway, John R.

AU - Boyer, Thomas D

AU - Bernardino, Michael E.

PY - 1993/7

Y1 - 1993/7

N2 - The authors retrospectively analyzed clinical records to determine the safety and complication rate of percutaneous ethanol ablation therapy with more than 10 mL of ethanol administered per session for treatment of malignant hepatic tumors. Ten patients underwent a total of 35 sessions with 10 mL or more of ethanol, and four underwent 18 sessions with 10 mL or less. No serious complications occurred with any dose. Pain and fever were the most common complications at all doses, and the higher frequency of these at larger ethanol volumes may be related to the greater degree of tumor necrosis induced by the larger volume.

AB - The authors retrospectively analyzed clinical records to determine the safety and complication rate of percutaneous ethanol ablation therapy with more than 10 mL of ethanol administered per session for treatment of malignant hepatic tumors. Ten patients underwent a total of 35 sessions with 10 mL or more of ethanol, and four underwent 18 sessions with 10 mL or less. No serious complications occurred with any dose. Pain and fever were the most common complications at all doses, and the higher frequency of these at larger ethanol volumes may be related to the greater degree of tumor necrosis induced by the larger volume.

KW - Alcohol, 761.1269

KW - Liver neoplasms, therapy, 761.1269, 761.323

KW - Liver, interventional procedures, 761.1269

UR - http://www.scopus.com/inward/record.url?scp=0027258795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027258795&partnerID=8YFLogxK

M3 - Article

VL - 188

SP - 283

EP - 285

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 1

ER -